GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ipca Laboratories Ltd (BOM:524494) » Definitions » Short-Term Debt

Ipca Laboratories (BOM:524494) Short-Term Debt : ₹0 Mil (As of Dec. 2023)


View and export this data going back to 1994. Start your Free Trial

What is Ipca Laboratories Short-Term Debt?

Ipca Laboratories's Short-Term Debt for the quarter that ended in Dec. 2023 was ₹0 Mil.

Ipca Laboratories's quarterly Short-Term Debt increased from Jun. 2023 (₹0 Mil) to Sep. 2023 (₹12,496 Mil) but then declined from Sep. 2023 (₹12,496 Mil) to Dec. 2023 (₹0 Mil).

Ipca Laboratories's annual Short-Term Debt increased from Mar. 2021 (₹2,432 Mil) to Mar. 2022 (₹3,961 Mil) and increased from Mar. 2022 (₹3,961 Mil) to Mar. 2023 (₹8,058 Mil).


Ipca Laboratories Short-Term Debt Historical Data

The historical data trend for Ipca Laboratories's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ipca Laboratories Short-Term Debt Chart

Ipca Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,241.00 3,788.60 2,432.10 3,960.60 8,057.50

Ipca Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 8,057.50 - 12,495.50 -

Ipca Laboratories Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.


Ipca Laboratories Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Ipca Laboratories's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Ipca Laboratories (BOM:524494) Business Description

Traded in Other Exchanges
Address
125, Kandivli Industrial Estate, Kandivli (West), Mumbai, MH, IND, 400067
Ipca Laboratories Ltd is a specialty and generic drug manufacturing company. The company's principal activity is Development, Manufacturing and Marketing of Pharmaceuticals Products. The company operates multiple subsidiaries with revenue generation split roughly between India and the rest of the world. Ipca's products are exported to more than 100 countries across the globe. Ipca has only one reportable primary business segment, pharmaceuticals.

Ipca Laboratories (BOM:524494) Headlines

No Headlines